Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 7,314 | 7,548 | 5,370 | 3,870 | 3,552 |
| Gross Profit | 7,314 | 7,548 | 5,370 | 3,870 | 3,552 |
| Operating Expenses | 95,534 | 100,951 | 90,182 | 87,872 | 81,797 |
| Operating Income | -88,220 | -93,403 | -84,812 | -84,002 | -78,245 |
| Interest Expense | 4 | 0 | 0 | 0 | 0 |
| Other Income | 119 | 84 | 148 | 225 | -90 |
| Pre-tax Income | -88,105 | -93,319 | -84,664 | -83,777 | -78,335 |
| Income Tax | N/A | 30 | N/A | 16 | N/A |
| Net Income Continuous | -88,105 | -93,349 | -84,664 | -83,793 | -78,335 |
| Net Income | $-88,105 | $-93,349 | $-84,664 | $-83,793 | $-78,335 |
| EPS Basic Total Ops | -21.75 | -24.00 | -22.50 | -22.75 | -21.50 |
| EPS Basic Continuous Ops | -21.87 | -24.02 | -22.61 | -22.73 | -21.41 |
| EPS Diluted Total Ops | -21.75 | -24.00 | -22.50 | -22.75 | -21.50 |
| EPS Diluted Continuous Ops | -21.87 | -24.02 | -22.61 | -22.73 | -21.41 |
| EBITDA(a) | $-86,131 | $-90,397 | $-82,095 | $-81,193 | $-75,663 |